Robotic exoskeleton shows promise for muscle disease patients

NCT ID NCT05200702

Symptom relief Sponsor: Institut de Myologie, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable robotic suit called MyoSuit that assists knee and hip movement in people with various muscle disorders. 32 participants used the device to perform walking tests, and researchers checked for safety and any immediate improvements in walking ability. The goal was to see if the suit is safe and helpful enough to consider for home use in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Knee-hip powered soft exoskeleton (MyoSuit)
What this could lead to: If successful, this device could help people with muscle disorders walk more easily and safely, potentially improving daily mobility.
What could go wrong: This was a small, early-stage study with only 32 participants, focused on short-term safety. It does not prove long-term benefits or work for all types of muscle conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Jan 2022

Finished

Jul 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years and \< 70 years of age * Height between 1.50 m and 1.95 m * Weight between 45 kg and 110 kg * Abdominal perimeter \< 125 cm * Written informed consent * Affiliate or beneficiary of a social security scheme * Able to comply with all protocol requirements * Confirmed diagnosis of a pathology belonging to one of the following family\*: * Primary disorders of muscles * Muscular dystrophy * Congenital myopathies * Idiopathic inflammatory myopathy * Mitochondrial myopathies * Metabolic disorders * Inborn errors of metabolism * Glycogen storage disease * Functional capacities: * Able to stand up from a chair with armrest without other supports at least 3 times and at most 15 times in 30 seconds. * Report the ability to walk without the assistance of a person at least 2min * The use of traditional orthoses and walking aids will be accepted excepted knee orthoses and walkers (e.g. canes/crutches, ankle foot orthosis). Exclusion Criteria: * Unable to participate in the study * Inability to comply with protocol requirements * Guardianship/trusteeship * Pregnant or nursing women * Unstable Cardiomyopathy * Symptomatic orthostatic hypotension * Medical history of osteoporotic fracture * Balance disorder with extra neuromuscular causes * Recent trauma (fall, accident, ...) * Unstable Cardiomyopathy * Severe respiratory insufficiency * Flexion contracture in the knee and hip joint in excess of 10° * Varus malposition in excess of 10° or valgus malposition in excess of 10°

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital myopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acquired idiopathic inflammatory myopathy congenital myopathy disorder of glycogen metabolism idiopathic inflammatory myopathy inborn mitochondrial myopathy muscle tissue disorder muscular dystrophy myositis disease neuromuscular disease Thomsen and Becker disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital myopathy Glycogen storage disease Idiopathic inflammatory myopathies Mitochondrial myopathies Muscular dystrophies

Robotic exoskeleton shows promise for muscle disease patients

What the study statuses mean